Peri-tumoral leakage during intra-tumoral convection-enhanced delivery has implications for efficacy of peri-tumoral infusion before removal of tumor

Drug Delivery

Volumn 23, Issue 3, 2016, Pages 781-786

  Yang, Xiaoliang ^a   Saito, Ryuta ^a   Nakamura, Taigen ^a   Zhang, Rong ^a   Sonoda, Yukihiko ^a   Kumabe, Toshihiro ^a   Forsayeth, John ^b   Bankiewicz, Krystof ^b   Tominaga, Teiji ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain tumor; Convection enhanced delivery; Drug delivery; Pre surgical infusion; Steroid

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; MACROGOL DERIVATIVE;

ANALOGS AND DERIVATIVES; ANIMAL; BLOOD BRAIN BARRIER; BRAIN; BRAIN NEOPLASMS; DRUG DELIVERY SYSTEM; METABOLISM; PHYSIOLOGY; PROCEDURES; RAT; THERMODYNAMICS; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD-BRAIN BARRIER; BRAIN; BRAIN NEOPLASMS; CELL LINE, TUMOR; CONVECTION; DOXORUBICIN; DRUG DELIVERY SYSTEMS; POLYETHYLENE GLYCOLS; RATS; TISSUE DISTRIBUTION;

EID: 84958175131     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2014.914987     Document Type: Article

References (23)

1. Baxter LT, Jain RK. (1989). Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection. Microvasc Res 37: 77-104
2. Bidros DS, Liu JK, Vogelbaum MA. (2010). Future of convection-enhanced delivery in the treatment of brain tumors. Future Oncol 6: 117-25
3. Bobo RH, Laske DW, Akbasak A, et al. (1994). Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci USA 91: 2076-80
4. Boucher Y, Baxter LT, Jain RK. (1990). Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. Cancer Res 50: 4478-84
5. Boucher Y, Jain RK. (1992). Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. Cancer Res 52: 5110-14
6. Boucher Y, Salehi H, Witwer B, et al. (1997) Interstitial fluid pressure in intracranial tumours in patients and in rodents. Br J Cancer 75:829-36
7. Brandes AA. (2003). State-of-the-art treatment of high-grade brain tumors. Semin Oncol 30: 4-9
8. DeAngelis LM. (2003). Benefits of adjuvant chemotherapy in high-grade gliomas. Semin Oncol 30: 15-18
9. Groothuis DR. (2000). The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery. Neuro-oncol 2: 45-59
10. Jemal A, Murray T, Samuels A, et al. (2003). Cancer statistics, 2003. CA Cancer J Clin 53: 5-26
11. Kikuchi T, Saito R, Sugiyama S, et al. (2008). Convection-enhanced delivery of polyethylene glycol-coated liposomal doxorubicin: characterization and efficacy in rat intracranial glioma models. J Neurosurg 109: 867-73
12. Kunwar S. (2003). Convection enhanced delivery of IL13-PE38QQR for treatment of recurrent malignant glioma: presentation of interim finDings from ongoing phase 1 studies. Acta Neurochir Suppl 88: 105-11
13. Kunwar S, Prados MD, Chang SM, et al. (2007) Cintredekin Besudotox Intraparenchymal Study Group. Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group. J Clin Oncol 25: 837-44
14. Navalitloha Y, Schwartz ES, Groothuis EN, et al. (2006). Therapeutic implications of tumor interstitial fluid pressure in subcutaneous RG-2 tumors. Neuro-oncol 8: 227-33
15. Rosenberg GA, Kyner WT, Estrada E. (1980). Bulk flow of brain interstitial fluid under normal and hyperosmolar conditions. Am J Physiol 238: F42-9
16. Saito R, Bringas JR, McKnight TR, et al. (2004) Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging. Cancer Res 64: 2572-9
17. Sampson JH, Archer G, Pedain C, et al. (2010). Poor drug distribution as a possible explanation for the results of the PRECISE trial. J Neurosurg 113: 301-9
18. Stupp R, Mason WP, van den Bent MJ, et al. (2005). Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-96
19. Sugiyama S, Yamashita Y, Kikuchi T, et al. (2007). Safety and efficacy of convection-enhanced delivery of ACNU, a hydrophilic nitrosourea, in intracranial brain tumor models. J Neurooncol 82: 41-7
20. Vogelbaum MA, Sampson JH, Kunwar S, et al. (2007). Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results. Neurosurgery 61: 1031-7
21. Walter KA, Tamargo RJ, Olivi A, et al. (1995). Intra-tumoral chemotherapy. Neurosurgery 37: 1128-45
22. Watanabe M, Tanaka R, Takeda N. (1992). Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology 34: 463-9
23. Yang W, Barth RF, Huo T, et al. (2014). Radiation therapy combined with intracerebral administration of carboplatin for the treatment of brain tumors. Radiat Oncol 9: 25